Genentech will be granted an exclusive license to develop and commercialize the degrader worldwide, and will be fully responsible for the development and commercialization costs.
The approved product has an estimated market size of around US$ 606 million for the twelve months ending June 2022, according to IQVIA.
QIAstat-Dx Viral Vesicular Panel tests for six pathogens that produce similar symptoms
Donor privilege cards given to the families of all the donors from across Karnataka as a token of appreciation
Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved in the US for children as young as five years of age
MeitY will provide technical support for digitalisation of the Ayush Sector under the Ayush Grid project for a period of three years
Apollo Hospital Group completed the acquisition of a hospital asset in Gurugram for a consideration of around Rs 450 crore.
APIC is a contract development and manufacturing organization (CDMO) that offers a wide range of services such as synthetic route design, pilot manufacturing, investigational medical manufacturing, and commercial production, by making full use of integrated processes that combine organic synthesis technologies and biotechnologies it has cultivated over many years
Both the plants have a total Capex of Rs. 75 crore and expected production timeline is Q3 FY23
Ivermectin Cream is a used for the treatment of inflammatory lesions of rosacea.
Subscribe To Our Newsletter & Stay Updated
